Development and Characterization of STAT3 Y705H Mutated Breast Cancer Cell Lines for Genetic Validation of the Mechanism of Action of STAT3 Inhibitor TTI-101

Authors

Matt S. MacArthur, The University of Texas MD Anderson Cancer CenterFollow
Moses M. Kasembeli, The University of Texas MD Anderson Cancer Center
David J. Tweardy, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

STAT3, TTI-101, IL6, tumorigenesis, CRISPR-Cas9

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

University Outreach - Augustana College

Recommended Citation

MacArthur, Matt S.; Kasembeli, Moses M.; and Tweardy, David J., "Development and Characterization of STAT3 Y705H Mutated Breast Cancer Cell Lines for Genetic Validation of the Mechanism of Action of STAT3 Inhibitor TTI-101" (2021). Summer Experience 2021. 219.
https://openworks.mdanderson.org/sumexp21/219